Showing results (101-110 of 27,651) with videos related to

Sort By:
Pageof 2,766
Vaccine|June 10, 2022
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccinesWilliam J Smith, Patrick L Ahl, Bei Wang, et al.
Vaccine|June 12, 2022
Development and immunogenicity evaluation of porcine deltacoronavirus inactivated vaccine with different adjuvants in miceFu-Jie Zhao, Lin-Tao Liu, Zi Wang, et al.
Vaccine|June 24, 2022
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccinesNatalia Abraham, Sarah Spruin, Tanya Rossi, et al.
Vaccine|June 24, 2022
Safety and immunogenicity of human rabies vaccine for the Chinese population after PEP: A systematic review and meta-analysisLei Wang, Jing Zhang, Shengli Meng, et al.
Vaccine|June 26, 2022
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273)Brett Leav, Walter Straus, Phil White, et al.
Vaccine|November 26, 2022
Simultaneous carriage of multiple serotypes of Group B Streptococcus: Systematic review and meta-analysisCamille Barro, Maha Salloum, Suzy Lim, et al.
Vaccine|November 27, 2022
Vaccine hesitancy educational tools for healthcare providers and trainees: A scoping reviewA Lip, M Pateman, M M Fullerton, et al.
Vaccine|June 17, 2022
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virusLibia Milena Hernandez, K Sumathy, Sushant Sahastrabuddhe, et al.
Vaccine|June 18, 2022
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trialsJordan B Braunfeld, Heather N Carson, Sarah R Williams, et al.
Vaccine|June 19, 2022
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interestPaul Moss, Francis Berenbaum, Giuseppe Curigliano, et al.
Pageof 2,766